J Rich Capital (JRC) is a cross-border strategic advisory firm that connects biotechnology innovation with global development and investment. Founded by professionals with backgrounds in life sciences, investment banking, and international business development, JRC helps biotech and pharmaceutical companies navigate the complex path from scientific discovery to global commercialization.

Our advisory practice integrates product development strategy, partnership structuring, and capital planning into one cohesive framework. We work with clients to accelerate R&D programs, design cross-border collaborations, and attract aligned investors who share a long-term vision for innovation.

Through our integrated approach—combining scientific insight, regulatory understanding, and financial expertise—JRC enables emerging biotech innovators to reach global markets faster and with greater strategic clarity. Our mission is simple: to turn scientific potential into sustainable, investable value.

Led by experts. Built for action.

JRC brings together a global team of seasoned professionals in drug development, regulatory affairs, clinical operations, market access, and business development.

Our leadership includes experienced biotech consultants, cross-border transaction specialists, former regulatory advisors, and KOLs from top academic institutions and trial networks.

What unites our team is not just experience—but a shared commitment to execution. We work hands-on alongside our clients to design realistic plans, coordinate across functions and geographies, and drive toward concrete milestones.